Eli Lilly has released more data for its obesity pill, Foundayo (orforglipron) in a rapid response to US regulators voicing certai...
Novo Nordisk has received a warning letter from the US Food and Drug Administration (FDA) related to the company’s failure to in...
The active pharmaceutical ingredient (API) landscape is shifting. Companies are rethinking their sourcing strategies, upgrading th...
The US Food and Drug Administration’s (FDA) scrutiny around medical device cybersecurity will “intensify significantly” as w...
Cell and gene therapies (CGT) offer hope to patients living with life-threatening conditions where limited treatment options may b...
Bioconjugation creates new molecules with increased stability and improved targeting. The process of joining proteins, peptides, o...
2024 saw the highest number of biosimilars approved by the US Food and Drug Administration (FDA) in a calendar year, with this yea...
Johnson & Johnson's (J&J) human neonatal Fc receptor (FcRn)-blocking monoclonal antibody Imaavy (nipocalimab-aahu) has rec...
The US Food and Drug Administration (FDA) has added haemodialysis bloodlines to its medical device shortages list amid supply disr...
The US Food and Drug Administration (FDA) has issued an early alert over a ‘potentially high-risk’ issue with certain Baxter S...